Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning : a randomised controlled trial
dc.contributor.author | Bateman, D Nicholas | |
dc.contributor.author | Dear, James W | |
dc.contributor.author | Thanacoody, H K Ruben | |
dc.contributor.author | Thomas, Simon H L | |
dc.contributor.author | Eddleston, Michael | |
dc.contributor.author | Sandilands, Euan A | |
dc.contributor.author | Coyle, Judy | |
dc.contributor.author | Cooper, Jamie G | |
dc.contributor.author | Rodriguez, Aryelly | |
dc.contributor.author | Butcher, Isabella | |
dc.contributor.author | Lewis, Steff C | |
dc.contributor.author | Vliegenthart, A D Bastiaan | |
dc.contributor.author | Veiraiah, Aravindan | |
dc.contributor.author | Webb, David J | |
dc.contributor.author | Gray, Alasdair | |
dc.date.accessioned | 2014-12-23T10:41:00Z | |
dc.date.available | 2014-12-23T10:41:00Z | |
dc.date.issued | 2014-02-22 | |
dc.identifier | 45139085 | |
dc.identifier | 2be97672-b077-48ca-bad4-2515a48c71fe | |
dc.identifier | 24290406 | |
dc.identifier | 84894030764 | |
dc.identifier.citation | Bateman , D N , Dear , J W , Thanacoody , H K R , Thomas , S H L , Eddleston , M , Sandilands , E A , Coyle , J , Cooper , J G , Rodriguez , A , Butcher , I , Lewis , S C , Vliegenthart , A D B , Veiraiah , A , Webb , D J & Gray , A 2014 , ' Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning : a randomised controlled trial ' , The Lancet , vol. 383 , no. 9918 , pp. 697-704 . https://doi.org/10.1016/S0140-6736(13)62062-0 | en |
dc.identifier.issn | 0140-6736 | |
dc.identifier.uri | http://hdl.handle.net/2164/4126 | |
dc.description | Copyright © 2014 Bateman et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd. All rights reserved. The trial was funded by Chief Scientist Office, Scotland (award CZB/4/722). | en |
dc.format.extent | 8 | |
dc.format.extent | 415339 | |
dc.language.iso | eng | |
dc.relation.ispartof | The Lancet | en |
dc.subject | Acetaminophen | en |
dc.subject | Acetylcysteine | en |
dc.subject | Adult | en |
dc.subject | Aged | en |
dc.subject | Alanine Transaminase | en |
dc.subject | Antiemetics | en |
dc.subject | Double-Blind Method | en |
dc.subject | Drug Administration Schedule | en |
dc.subject | Drug Therapy, Combination | en |
dc.subject | Female | en |
dc.subject | Great Britain | en |
dc.subject | Humans | en |
dc.subject | Infusions, Intravenous | en |
dc.subject | Liver Failure, Acute | en |
dc.subject | Male | en |
dc.subject | Middle Aged | en |
dc.subject | Nausea | en |
dc.subject | Ondansetron | en |
dc.subject | Poisoning | en |
dc.subject | Treatment Outcome | en |
dc.subject | Vomiting | en |
dc.subject | R Medicine | en |
dc.subject.lcc | R | en |
dc.title | Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning : a randomised controlled trial | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1016/S0140-6736(13)62062-0 |